| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kamila Kitowska, Dariusz Zakrzewicz, Melanie K\\xc3\\xb6nigshoff, Izabella Chrobak, Friedrich Grimminger, Werner Seeger, Patrick Bulau, Oliver Eickelber. Functional role and species-specific contribution of arginases in pulmonary fibrosis. American journal of physiology. Lung cellular and molecular physiology vol 294 issue 1 2008 17934065 |
l-arginine is a key precursor of nitric oxide, asymmetric dimethylarginine, and proline, an amino acid enriched in collagen. |
2008-04-10 |
2023-01-24 |
mouse |
| Dennis Schade, Katrin T\\xc3\\xb6pker-Lehmann, J\\xc3\\xbcrke Kotthaus, Bernd Clemen. Synthetic approaches to N(delta)-methylated L-arginine, N(omega)-hydroxy-L-arginine, L-citrulline, and N(delta)-cyano-L-ornithine. The Journal of organic chemistry vol 73 issue 3 2008 18179234 |
nomega-methylated arginines such as asymmetric dimethyl-l-arginine (adma) and monomethyl-l-arginine (nmma) are known as potent physiological inhibitors of nitric oxide synthases (noss). |
2008-04-03 |
2023-01-24 |
Not clear |
| E Leifke, M Kinzel, D Tsikas, L Gooren, J C Fr\\xc3\\xb6lich, G Braban. Effects of normalization of plasma testosterone levels in hypogonadal men on plasma levels and urinary excretion of asymmetric dimethylarginine (ADMA). Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme vol 40 issue 1 2008 18176911 |
elevated plasma levels of asymmetric dimethylarginine (adma) inhibit nitric oxide formation and exert a proatherogenic action. |
2008-03-26 |
2023-01-24 |
Not clear |
| Mahmut Ilker Yilmaz, Alper Sonmez, Mutlu Saglam, Abdul R Qureshi, Juan Jesus Carrero, Kayser Caglar, Tayfun Eyileten, Erdinc Cakir, Yusuf Oguz, Abdulgaffar Vural, Mujdat Yenicesu, Bengt Lindholm, Peter Stenvinkel, Jonas Axelsso. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction. Journal of the American Society of Nephrology : JASN vol 19 issue 2 2008 18199801 |
asymmetric dimethyl-arginine (adma), a residue of the proteolysis of arginine-methylated proteins, is a potent inhibitor of nitric oxide synthesis. |
2008-02-29 |
2023-01-24 |
Not clear |
| Lin Hong, Walter Fas. Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide. Analysis, quantification, and implications for hyperhomocysteinemia. The Journal of biological chemistry vol 282 issue 48 2008 17895252 |
the plasma concentrations of two cardiovascular risk factors, total homocysteine (thcy) and asymmetric dimethylarginine (adma), correlate with decreased levels of endothelium-derived nitric oxide and subsequent endothelial dysfunction. |
2008-02-04 |
2023-01-24 |
human |
| Sihe Wang, Faye B Vicente, Alan Miller, Ellen R Brooks, Heather E Price, Frederick A Smit. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry. Clinical chemistry and laboratory medicine vol 45 issue 10 2008 17663630 |
the arginine derivatives asymmetric dimethylarginine (adma) and symmetric dimethylarginine (sdma) interfere with endothelial nitric oxide synthesis. |
2008-01-17 |
2023-01-24 |
Not clear |
| Hillevi Blomster, Tuomo Puustj\\xc3\\xa4rvi, Matti Kontkanen, Pirjo Valtonen, Markku Ter\\xc3\\xa4svirta, Hannu Uusital. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie vol 245 issue 2 2007 17024436 |
asymmetric dimethylarginine (adma) is an endogenous inhibitor of endothelial nitric oxide and plasma level of adma is often elevated in hh. |
2007-12-18 |
2023-01-24 |
Not clear |
| Barbaros Balabanli, H\\xc3\\xbcsamettin Erdamar, Nurten T\\xc3\\xbcrk\\xc3\\xb6zkan, Halil Yaman, Yasemin Kur. Effect of taurine on endotoxin-induced alterations in plasma asymmetric dimethylarginine, L-arginine and nitric oxide in guinea pigs. Journal of thrombosis and thrombolysis vol 24 issue 1 2007 17310400 |
effect of taurine on endotoxin-induced alterations in plasma asymmetric dimethylarginine, l-arginine and nitric oxide in guinea pigs. |
2007-11-05 |
2023-01-24 |
Not clear |
| Toyotaka Yada, Shuichiro Kaji, Takashi Akasaka, Seiichi Mochizuki, Yasuo Ogasawara, Kazuo Tanemoto, Kiyoshi Yoshida, Fumihiko Kajiy. Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. Clinical hemorheology and microcirculation vol 37 issue 3 2007 17726257 |
changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments. |
2007-11-02 |
2023-01-24 |
human |
| Inga Soveri, Lars Lind, Bj\\xc3\\xb6rn Wikstrom, Mihkel Zilmer, Kersti Zilmer, Bengt Fellstr\\xc3\\xb6. Improvement in central arterial pressure waveform during hemodialysis is related to a reduction in asymmetric dimethylarginine (ADMA) levels. Nephron. Clinical practice vol 106 issue 4 2007 17596727 |
early arterial pressure wave reflections, reflecting arterial stiffness and the endogenous nitric oxide synthesis inhibitor asymmetric dimethylarginine (adma) levels predict mortality in hd patients. |
2007-09-04 |
2023-01-24 |
Not clear |
| Hilde M A Eid, Harald Arnesen, Elsa M Hjerkinn, Torstein Lyberg, Ingrid Ellingsen, Ingebj\\xc3\\xb8rg Seljeflo. Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine. Nutrition & metabolism vol 3 issue 2007 16396682 |
impaired vasodilatation has been suggested to be caused by inhibition of nitric oxide generation by the recently described asymmetric dimethylarginine (adma). |
2007-07-25 |
2023-01-24 |
Not clear |
| Lijun Xu, Bingyin Wang, Kirandeep Kaur, Melanie F Kho, John P Cooke, Rona G Giffar. NOx and ADMA changes with focal ischemia, amelioration with the chaperonin GroEL. Neuroscience letters vol 418 issue 2 2007 17398004 |
both nitric oxide and asymmetric dimethylarginine (adma) play a critical role in the regulation of cerebral blood flow, though their neuroprotective and cytotoxic effects are still under investigation. |
2007-07-25 |
2023-01-24 |
rat |
| Zhi-Chun Yang, Ke Xia, Li Wang, Su-Jie Jia, Dai Li, Zhe Zhang, Shen Deng, Xiao-Hong Zhang, Han-Wu Deng, Yuan-Jian L. Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rats. Microvascular research vol 73 issue 2 2007 17098259 |
after incubation of erythrocytes with asymmetric dimethylarginine (10(-6) m) for 30 min, erythrocyte deformability and nitric oxide level in erythrocytes were decreased markedly. |
2007-04-24 |
2023-01-24 |
rat |
| Zhi-Chun Yang, Ke Xia, Li Wang, Su-Jie Jia, Dai Li, Zhe Zhang, Shen Deng, Xiao-Hong Zhang, Han-Wu Deng, Yuan-Jian L. Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rats. Microvascular research vol 73 issue 2 2007 17098259 |
these results indicated that reduction of erythrocyte deformability in diabetic rats was associated with promoted oxidant stress as well as impaired nitric oxide synthesis by elevation of asymmetric dimethylarginine. |
2007-04-24 |
2023-01-24 |
rat |
| Narbeh Melikian, Stephen B Wheatcroft, Okechukwu S Ogah, Cliona Murphy, Phillip J Chowienczyk, Anthony S Wierzbicki, Thomas A B Sanders, Benyu Jiang, Edward R Duncan, Ajay M Shah, Mark T Kearne. Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young Black African men. Hypertension (Dallas, Tex. : 1979) vol 49 issue 4 2007 17261643 |
asymmetric dimethylarginine and reduced nitric oxide bioavailability in young black african men. |
2007-04-05 |
2023-01-24 |
human |
| Phillip E Gates, Meghan L Boucher, Annemarie E Silver, Kevin D Monahan, Douglas R Seal. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. Journal of applied physiology (Bethesda, Md. : 1985) vol 102 issue 1 2007 16946027 |
impaired fmd may be mediated in part by a decrease in synthesis of nitric oxide by endothelial nitric oxide synthase, and in clinical populations this has been attributed to competitive inhibition of l-arginine binding sites by asymmetric dimethylarginine (adma). |
2007-03-13 |
2023-01-24 |
human |
| Usman Khan, Ahamad Hassan, Patrick Vallance, Hugh S Marku. Asymmetric dimethylarginine in cerebral small vessel disease. Stroke vol 38 issue 2 2007 17204687 |
asymmetric dimethylarginine (adma), a circulating endogenous inhibitor of nitric oxide, has been implicated in endothelial dysfunction, particularly in hyperhomocystinemia, a known risk factor for svd. |
2007-03-12 |
2023-01-24 |
Not clear |
| Asife Sahinarslan, Atiye Cengel, Gursel Biberoglu, Alev Hasanoglu, Sedat Turkoglu, Timur Timurkayna. Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography. Coronary artery disease vol 17 issue 7 2007 17047444 |
given that the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, can decrease nitric oxide bioavailability and lead to atherosclerosis, its concentration can be a good predictor for coronary artery disease. |
2007-01-30 |
2023-01-24 |
Not clear |
| Mehmet Sahin, Cagatay Arslan, Mustafa Naziroglu, S Ercan Tunc, Mustafa Demirci, Recep Sutcu, Nigar Yilma. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. Annals of clinical and laboratory science vol 36 issue 4 2007 17127734 |
asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in behcet's disease. |
2007-01-09 |
2023-01-24 |
human |
| Friedrich Mittermayer, Katarzyna Krzyzanowska, Markus Exner, Wolfgang Mlekusch, Jasmin Amighi, Schila Sabeti, Erich Minar, Markus M\\xc3\\xbcller, Michael Wolzt, Martin Schillinge. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease. Arteriosclerosis, thrombosis, and vascular biology vol 26 issue 11 2006 16931791 |
circulating concentrations of asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthesis, are elevated in conditions associated with increased cardiovascular risk. |
2006-11-13 |
2023-01-24 |
Not clear |